Lysophosphatidic acid (LPA) is an abundant cellular lipid with a myriad of biological effects. It plays an important role in both inter-and intracellular signaling. Activation of the LPA 1-3 G-protein-coupled receptors explains many of the extracellular effects of LPA, including cell growth, differentiation, survival, and motility. However, LPA also acts intracellularly, activating the nuclear hormone receptor peroxisome proliferator-activated receptor-␥ that regulates gene transcription. This study shows that the novel subfamily of mechano-gated K 2P channels comprising TREK-1, TREK-2, and TRAAK is strongly activated by intracellular LPA. The LPA-activated 2P domain K ؉ channels are intracellular ligandgated K ؉ channels such as the Ca 2؉ -or the ATP-sensitive K ؉ channels. LPA reversibly converts these mechano-gated, pH-and voltage-sensitive channels into leak conductances. Gating conversion of the 2P domain K ؉ channels by intracellular LPA represents a novel form of ion channel regulation. Thus, the TREK and TRAAK channels should be included in the LPA-associated physiological and disease states.
K
ϩ channels form the largest family of ion channels, with about 80 different genes cloned in human. Alternative splicing, heteromultimerization, regulatory proteins, and posttranslational modifications contribute to increase this molecular complexity. At the functional level, K ϩ channels are characterized by different gating mechanisms that condition their role in cell electrogenesis. Voltage, Ca 2ϩ , G-proteins, the ATP/ADP ratio, and phosphatidylinositol 4,5-bisphosphate are among the key regulators of K ϩ channel gating (1) (2) (3) (4) . For instance, closing of the K ATP channels in ␤ pancreatic cells, when the ATP/ADP ratio increases, is responsible for membrane depolarization, increase in intracellular Ca 2ϩ , and release of insulin upon glucose stimulation (5) .
The 2P domain K ϩ (K 2P ) 1 channel family of mammalian K ϩ channel subunits are distinguished by four transmembrane segments and two P domains in tandem that contribute to the ionic pore (6 -11) . So far, 15 human K 2P subunits have been identified. Some of these K 2P channels have a highly restricted tissue expression, for instance TALK-1 in the pancreas, whereas others, including TREK-1, have a more widespread expression (12, 13) . K 2P subunits dimerize to form functional K ϩ channels, and heteromultimerization has been demonstrated for TASK-1 and -3 (14 -16) . A large majority of the K 2P channels behave as typical background K ϩ channels, opened at physiological pH (the TWIK, TASK, THIK, and TRESK channels) or during extracellular alkalosis (the TALK channels) (6, 7, 9, 10) . By contrast, the TREK/TRAAK K 2P channels require either a physical or chemical stimulation to open (12, (17) (18) (19) (20) (21) (22) (23) (24) (25) .
The TREK and TRAAK channels are the first mammalian mechano-gated ion channels that have been cloned (Refs. 6, 11, 12 , and 17 and reviewed in Refs. 26 and 27) . At atmospheric pressure, their open probability is low but is dose dependent and reversibly increased by membrane stretch (17, 19, 21, 28) . Furthermore, TREK-1 and TREK-2 are stimulated by intracellular acidosis, whereas TRAAK opens upon intracellular alkalosis (19, 20, 28, 29) . TREK-1 is additionally opened by heat, whereas it closes upon cooling (18) . Various chemical agents are also potent modulators of TREK-1 (6, 11, 30) . Polyunsaturated fatty acids, including arachidonic acid (AA), reversibly open the TREK and TRAAK channels (17, 24, 28, 31) . Additionally, extracellular lysophospholipids, including LPC, unlike extracellular lysophosphatidic acid (LPA), are also potent openers of TREK-1 (32) . Although AA stimulation is apparently direct, extracellular lysophospholipids fail to modulate TREK-1 activity after patch excision (11, 32) . On the contrary, intracellular LPC inhibits TREK-1 channel activity (32) . Importantly TREK-1 and TREK-2, unlike TRAAK, are stimulated by volatile and gaseous anesthetics (23, 33) . These channels are also opened by the neuroprotective agent riluzole (25) . On the contrary, the cationic amphipaths, including chlorpromazine (CPZ), tetracaine, and bupivacaine, are inhibitors of TREK-1 (17, 34) . Stimulation of the cAMP-dependent protein kinase pathway inhibits TREK-1 by phosphorylation of Ser-333 in the cytosolic carboxyl-terminal domain (17) . Moreover, stimulation of the metabotropic glutamate receptors down-modulates TREK-1 via a direct inhibition by diacylglycerol, independently of the protein kinase C pathway (35) . Recent in vivo evidence confirms a key role for TREK-1 in neuroprotection by polyunsaturated fatty acids as well as in general anesthesia (36) .
LPA is an abundant cellular lipid that exerts multiple biological effects (37) (38) (39) (40) (41) . Extracellular LPA evokes biological responses that are mediated through the activation of three Gprotein-coupled receptors (LPA 1-3 ). Although important progress has been made in the understanding of the extracellular effects of LPA and its role in disease states such as cancer progression and atherosclerosis, the role of intracellular LPA has only recently been recognized (42) (43) (44) . The tissue concentration of LPA is remarkably high, reaching up to 100 nmol/g in the brain (38, 41) . Cellular LPA is produced by glycerophosphate acyltransferase and by monoacylglycerol kinase and is a critical first step in the formation of triacylglycerol and glyc-erophospholipids. The hydrolysis of phosphatidic acid (PA) by phospholipases A 1 and A 2 , the hydrolysis of lysophospholipids by lysophospholipase D, and the oxidative modification of low density lipoproteins lead to locally generated extracellular LPA, which is able to cross the plasma membrane and combine with the transcription factor peroxisome proliferator-activated receptor-␥ (43). Thus, LPA also acts as a paracrine signal and behaves as a transcellular agonist (42, 43) .
In the present study, we demonstrate that intracellular LPA is a potent regulator of the TREK/TRAAK K 2P channels. This is the first demonstration of an LPA-operated ion channel family. Opening of these K 2P channels by intracellular LPA directly links the lipid status to cell electrogenesis.
MATERIALS AND METHODS
Neuronal Cell Cultures-The primary culture of mouse striata was carried out as described previously (36) . Cells were plated in culture dishes coated previously with polyornithine and 50% fetal calf serum. The culture was Dulbecco's modified Eagle's medium (Invitrogen) with glucose (1.5 g/liter) for 24 h and then B27 with uridine (2 M) and 5-fluoro-2Ј-deoxyuridine (2 M).
Electrophysiological Recordings-Patch clamp measurements of neurons were performed 2 or 3 days after plating. In inside-out configuration, the internal solution contained (in mM): 155 KCl, 5 EGTA, and 10 HEPES, pH 7.2, with KOH, and the external solution contained (in mM): 120 NaCl, 5 KCl, 3 MgCl 2 , 1 CaCl 2 , and 10 HEPES, pH 7.4, with NaOH. 10 mM tetraethylammonium chloride, 3 mM 4-aminopyridine, 10 M glibenclamide, and 5 mM glucose were added daily to the extracellular solution, and pH was adjusted with HCl. For COS cell experiments, culture, mutagenesis, transfection, and the electrophysiological procedure have been detailed elsewhere (17, 19, 20, 22) . The long spliced form of mTREK-1, with an extension of 15 amino acids in the amino-terminal domain, was used in the present study (45) . In some experiments, an amino-terminal enhanced yellow fluorescent proteintagged mTREK-1 channel was used, and no functional difference with the untagged WT channel was observed, including sensitivity to intracellular LPA. For clarity and consistency with our previous work, amino acid numbering was related to the short mTREK-1 splice variant (12) . mTREK-1, rTREK-2, mTRAAK, and mTRESK-1 were used in this study. We routinely transfected 0.1 g of DNA for each 35-mm-diameter plate containing 20,000 cells. The external medium contained (in mM): 150 NaCl, 5 KCl, 3 MgCl 2 , 1 CaCl 2 , and 10 HEPES, pH 7.4, with NaOH. To study the voltage dependence of TREK-1, we used an extracellular medium containing (in mM): 155 KCl, 5 EGTA, 5 EDTA, and 10 HEPES, pH 7.4, with KOH. The intracellular medium contained (in mM): 155 KCl, 5 EGTA, 10 HEPES, pH 7.2, with KOH. Inside-out patches were routinely held at a holding potential of Ϫ80 mV and stimulated by voltage ramps of 660 ms in duration from Ϫ100 mV to 100 mV every 5 s. LPA (Sigma and Avanti Polar Lipids), PA (Sigma), and oleoylglycerol (Sigma) were dissolved in a mixture of chloroform/methanol/water/HCl (20:10:1:1) at a concentration of 5 mM, 25 mM, and 7 mM, respectively. Sphingosine-1P (Sigma) was dissolved in methanol at 2 mM. Aliquots were kept under argon at Ϫ80°C. Daily, aliquots were evaporated with air, and lipids were dissolved in the saline solution that was sonicated on ice for 15 min before use. Control experiments were carried out using the evaporated solvent alone. AA and oleic acid (Sigma) were dissolved in ethanol at a concentration of 100 mM, kept at Ϫ20°C, and renewed weekly. Glycerophosphate and pyrophosphate (Sigma) were dissolved in water at a concentration of 5 mM. Chlorpromazine was dissolved in 10% ethanol at a concentration of 10 mM and stored at Ϫ20°C. Mibefradil (Sigma) was dissolved in water at a concentration of 10 mM and stored at Ϫ20°C. ATP K ϩ salt (5 mM) was dissolved in the saline solution. The Student's t test (paired or unpaired) was used for statistical analysis. Differences were considered significant at p Ͻ 0.05 (as indicated by asterisks in the figures).
RESULTS
Intracellular LPA Stimulates TREK-1 Channel Activity-We expressed TREK-1 in transiently transfected COS cells and recorded channel activity in the inside-out patch configuration ( Fig. 1) . TREK-1 is reversibly opened by the addition of 5 M oleoyl-LPA to the intracellular medium ( Fig. 1, A and B) . The LPA-activated current is not present in mock-transfected COS cells (n ϭ 12; Fig. 1D ) or in cells expressing TRESK-1 (n ϭ 15), another K 2P channel that is functionally unrelated to TREK-1 Membrane current was recorded with a voltage ramp applied from a holding potential of Ϫ80 mV. C, the effect of intracellular LPA is dose-dependent, and the dose-effect curve was fitted with a sigmoidal Hill function. Concentrations of LPA Ͼ30 M consistently lead to patch rupture (n ϭ 4). Shown is the comparison of the effect of intra-and extracellular LPA (3 M) applied to the inside-out (I-O) (n ϭ 10), whole-cell (WC) (n ϭ 4), and outside-out (O-O) patch configurations (n ϭ 9) (inset). D, 5 M LPA (n ϭ 50) and PA (n ϭ 18) produce a significant stimulation of TREK-1 current amplitude. No significant effect is observed with control mock-transfected cells (n ϭ 12), glycerol (n ϭ 5), glycerophosphate (n ϭ 11), oleoylglycerol (n ϭ 12), pyrophosphate (n ϭ 5), or oleic acid (n ϭ 7) at 5 M. ATP (n ϭ 6) was tested at a concentration of 5 mM. Currents were measured at 90 mV. *, p Ͻ 0.05. (46, 47) . Thus, the LPA-activated K ϩ current originates from TREK-1 ( Fig. 1, B-D) . The time constants for channel activation and recovery are ϭ 14.9 Ϯ 4.8 s and ϭ 51.1 Ϯ 10.1 s (n ϭ 8), respectively. LPA induces a typical outwardly rectifying I-V curve that reverses at the predicted K ϩ equilibrium potential (Fig. 1B) . Channel activation is reproduced several times on the same patch (not shown). Intracellular LPA opens TREK-1 in a dose-dependent manner with an EC 50 of 2.4 Ϯ 0.2 M (n ϭ 10) and with a very steep concentration-response relationship (Fig. 1C) . LPA preferentially activates TREK-1 when applied intracellularly, whereas, as reported previously (32), extracellular LPA only has a minimum effect in the whole-cell, outsideout, and cell-attached patch configurations (2.4 Ϯ 0.3-fold, n ϭ 3) (Fig. 1C, inset) . LPA activation is dependent on the presence of the phosphate head group (Fig. 1, A and D) . Indeed, oleoylglycerol that lacks the phosphate at position 3 of the glycerol is completely ineffective (n ϭ 12). The acyl chain is also required, as glycerophosphate (n ϭ 11) is without significant effect on TREK-1 (Fig. 1, A and D) . Oleic acid (n ϭ 7), glycerol (n ϭ 5), and pyrophosphate (n ϭ 5) do not significantly alter TREK-1 channel activity (Fig. 1, A and D) . Intracellular ATP (5 mM) produces a mild, although significant, reversible inhibition of TREK-1 (Ϫ22 Ϯ 4%, n ϭ 6) (Fig. 1D) . Intracellular stearic LPA, comprising a saturated fatty acid at position 1, potently and equally opens TREK-1 (I/I control: 74 Ϯ 27, n ϭ 13) (not shown). Intracellular PA induces channel activation (n ϭ 18), although stimulation is weak compared with LPA (Fig. 1D) . Sphingosine 1P is without any significant effect (I/I control: 1.5 Ϯ 0.7, n ϭ 11) (not shown).
LPA Converts the Voltage-sensitive K ϩ Channel TREK-1 into a Leak Conductance-TREK-1 displays intrinsic voltage dependence (22, 45) . In a symmetrical K ϩ gradient lacking both intra-and extracellular Mg 2ϩ , TREK-1 shows kinetics of activation and deactivation as well as a strong outward rectification (Fig. 2) . During a voltage pulse to 100 mV, the steady-state outward current (I st ) increases by about 2-fold as compared with the initial current (I t0 ) (Fig. 2, A-C) . In the presence of intracellular LPA, the activation of the current becomes instantaneous (Fig. 2, A-C) . Moreover, the time constant for current deactivation at Ϫ80 mV following a voltage step to 100 mV is significantly enhanced from 7.8 Ϯ 1.1 ms to 23.5 Ϯ 5.7 ms (n ϭ 11) in the presence of LPA (Fig. 2, A and B) . Alteration of current kinetics by intracellular LPA is particularly evident when currents are normalized (Fig. 2B) . A partial relaxation of the current is evident at depolarized potentials ( ϭ 41.2 Ϯ 4.8 ms at 100 mV, n ϭ 6) (Fig. 2, A and B) . The typical outward rectification of TREK-1 is reversibly abrogated by intracellular LPA (Fig. 2D) . Consequently, the stimulation by LPA is stronger at negative (89.8 Ϯ 35.6-fold at Ϫ140 mV, n ϭ 10) versus positive potentials (18.9 Ϯ 6.4-fold at 140 mV, n ϭ 10).
Intracellular LPA and pH Activation of TREK-1 Are Not Additive-TREK-1 is rapidly and reversibly activated by intracellular acidosis (19) (Fig. 3A) . At intracellular pH 5.5, LPA fails to further open TREK-1 (Fig. 3A) . Protonation of LPA at acidic intracellular pH may reduce the net negative charge of the molecule, thus affecting TREK-1 stimulation. Another possibility is that LPA and acidic activations are not additive. Protonation of the amino acid Glu-306, located in the proximal cytosolic carboxyl-terminal domain, is critical for acid activation of TREK-1 (20) . Substitution of Glu-306 by an alanine mimics the effect of acidosis and locks the channel in the open conformation (20) . The E306A mutant, unlike TREK-1 WT, is characterized by a constitutive activity at intracellular pH 7.2 (20) (Fig. 3B) . Intracellular LPA only produces a modest increase in the E306A current amplitude, an observation that is consistent with previous findings indicating that TREK-1 E306A is fully activated and cannot be further stimulated by intracellular acidification or membrane stretch (20) (Fig. 3B) . This result suggests that acidic and LPA activations are indeed not additive. The double mutant ⌬C100 E306A, with a deletion of the last 100 amino acids in the carboxyl-terminal domain, is significantly stimulated by intracellular LPA, indicating that Glu-306 does not directly participate in the LPA effect (Fig. 3,  C and D) .
LPA Converts the Mechano-gated Channel TREK-1 into a Background Channel-At atmospheric pressure, TREK-1 channel activity is low (Fig. 4, A and C) . A membrane stretch of Ϫ60 mm Hg (suction on the patch of membrane) reversibly opens TREK-1 channels (Fig. 4, A-C) . TREK-1 channel activity is directly related to pressure with a P 0.5 value of Ϫ23.0 Ϯ 6.5 mm Hg (n ϭ 6) (Fig. 4B) . In the presence of intracellular LPA, TREK-1 is opened at atmospheric pressure, and membrane stretch fails to significantly increase channel activity (Fig. 4,  A-C) . The carboxyl-truncated mutant ⌬C103 is characterized by a P 0.5 value of Ϫ46.5 Ϯ 2.7 mm Hg (n ϭ 8), demonstrating a lower mechano-sensitivity (Fig. 4, D and E) . In the presence of C, activation kinetic of TREK-1 (n ϭ 10 and n ϭ 9 for control and LPA, respectively) estimated by the ratio of the steady-state (I st ) over the initial current amplitude (I t0 ) measured at 100 mV. D, average I-V curve of TREK-1 in control (n ϭ 9) and in the presence of 5 M LPA (n ϭ 10) in the intracellular medium. The top inset illustrates the effect of LPA on the outward rectification of TREK-1 (n ϭ 10 and n ϭ 9 for control and LPA, respectively) estimated by the ratio of current amplitude measured at Ϫ80 mV and 80 mV, and the lower inset magnifies the control I-V curve. *, p Ͻ 0.05. intracellular LPA, channel activity at atmospheric pressure strongly increases, and the P 0.5 value is shifted to Ϫ11.3 Ϯ 4.7 mm Hg (n ϭ 6) (Fig. 4, D and E) . The activity of ⌬C103, unlike TREK-1 WT (Fig. 5C, inset) , is significantly enhanced by membrane stretch in the presence of intracellular LPA (Fig. 4, D-F) . Because of a lower basal P 0.5 value, ⌬C103 remains mechanosensitive in the presence of intracellular LPA (Fig. 4, D-F) . This result demonstrates that LPA shifts the pressure-effect curve of TREK-1 toward more positive pressure (Fig. 4, B and E) .
Differential Activation of TREK-1 by LPA and AA but Shared Inhibition by CPZ-Intracellular LPA (5 M) and AA (5 M) increase TREK-1 activity to a similar extent at atmospheric pressure (Fig. 5A) . The cytosolic amino-terminal domain of TREK-1 is not required for the effect of both lipids (Fig. 5A) . On the contrary, LPA activation is enhanced by the carboxyl-terminal deletions, whereas AA activation is diminished (Fig. 5A) . A cluster of charges located between Arg-297 and Arg-311, containing the glutamate residue Glu-306, plays a key role in the up-regulation of TREK-1 and TREK-2 by AA (17, 48) . Substitution of each of the five positively charged residues in the proximal carboxyl-terminal domain by an alanine fails to significantly affect channel stimulation by LPA (n ϭ 8) (Fig.  5A, plus signs) . To investigate the role of the short intracellular loop M2M3, we constructed a chimera between the core of TREK-1 and the M2M3 intracellular loop of TRESK-1, a K 2P channel that is not stimulated by intracellular LPA (n ϭ 15). Although the TREK-1/TRESK-1 chimera displays a reduced sensitivity to intracellular pH 5.5 (1.54 Ϯ 0.21-fold, n ϭ 7 versus 17.7 Ϯ 3.2-fold, n ϭ 28 for WT), AA (2.9 Ϯ 0.5-fold, n ϭ 6 versus 53 Ϯ 11-fold, n ϭ 10 for WT), and stretch (I Ϫ44 mm Hg / I 0 mm Hg ϭ 2.34 Ϯ 0.34-fold, n ϭ 5 versus 108 Ϯ 29-fold, n ϭ 12 for WT), it remains significantly, although weakly, activated by intracellular LPA (2.66 Ϯ 0.36-fold, n ϭ 10 versus 45 Ϯ 8 for the WT, n ϭ 50) (not shown). Unlike anionic polyunsaturated fatty acids, cationic amphipaths, including CPZ, are potent inhibitors of TREK-1. For instance, CPZ reverses TREK-1 activation by AA (17) . Similarly, CPZ reversibly inhibits the basal as well as the LPAstimulated TREK-1 current (Fig. 5, B and C) . Mibefradil is a potent inhibitor of bTREK-1 (49) . Similarly, the basal and the LPA-stimulated mTREK-1 currents are reversibly inhibited by 3 M mibefradil (Ϫ63 Ϯ 8%, n ϭ 6 and Ϫ68 Ϯ 6%, n ϭ 9, respectively) when applied intracellularly in the inside-out patch configuration (not shown). 10 M mibefradil further inhibits the LPA-activated TREK-1 currents by Ϫ86 Ϯ 8% (n ϭ 7).
The TREK/TRAAK Subunit Family Is Up-regulated by Intracellular LPA-TREK-2 and TRAAK are, similar to TREK-1, stimulated by membrane stretch and polyunsaturated fatty acids (21, 29, 31, 48, 50) . Both channels are also reversibly activated by intracellular LPA at atmospheric pressure (Fig.  6A) . TRAAK shows the highest sensitivity to intracellular LPA (342 Ϯ 65-fold increase) compared with TREK-1 (45 Ϯ 8-fold increase, n ϭ 50) and TREK-2 (10 Ϯ 3-fold increase, n ϭ 9) (Fig.  6, A and B) . Intracellular LPA shifts the mechano-sensitivity of TRAAK toward lower pressure values (n ϭ 4), leading to channel opening at atmospheric pressure (Fig. 6C) .
LPA Activates the Native Neuronal TREK-1 Channel-TREK-1 is highly expressed in the caudate nucleus and the putamen (12, 51, 52) . Endogenous K 2P channels were recorded from cultured isolated mouse embryo striatal neurons. Insideout patches were excised in the presence of 10 mM tetraethylammonium, 3 mM 4-AP, and 10 M glibenclamide in the pipette and with an intracellular Ca 2ϩ -free medium at a holding potential of 0 mV. This experimental paradigm was designed to minimize the contribution of voltage-gated, Ca 2ϩ -sensitive, and K ATP channels. Basal channel activity is low under these conditions (Fig. 7) . Lowering intracellular pH from 7.2 to 5.5 induces a robust and reversible activation of a K ϩ channel of 55.8 Ϯ 0.9 picosiemens at 50 mV (n ϭ 6; physiological K ϩ gradient) (Fig. 7) . Channel activity flickers greatly, and openings occur in bursts (Fig. 7, A and B) . The I-V curve is outwardly rectifying and reverses at the predicted equilibrium potential for K ϩ (not shown). This channel is additionally opened by membrane stretch and by the addition of AA to the intracellular medium (Fig. 7C) . The biophysical and pharmacological properties of this neuronal K ϩ channel are similar to those described previously for TREK-1 (17) . Moreover, the 55-picosiemens striatal K ϩ channel is absent in striatal neurons from TREK-1Ϫ/Ϫ mice (36), thus confirming its molecular identity. Addition of 5 M LPA to the intracellular side produces a very potent and reversible stimulation of channel opening (Fig. 7) . The LPA stimulation is comparable in magnitude to the effect of intracellular acidosis, although onset and offset kinetics are slower (Fig. 7A) .
DISCUSSION
It was recently demonstrated that LPA, besides activating the extracellular G-protein-coupled membrane receptors LPA 1-3 , also acts intracellularly to control gene transcription mediated by nuclear hormone receptors (42, 43) . In the present report, we provide evidence that the novel subfamily of mechano-gated K 2P channels comprising TREK-1, TREK-2, and TRAAK is potently activated by intracellular LPA. Channel mechano-sensitivity is drastically and reversibly altered by intracellular LPA.
TREK-1 is a mechano-gated K 2P channel that is opened by intracellular acidosis, by extracellular LPC, and by AA (6, 11, 30, 32) . We demonstrate that intracellular LPA, in the micromolar range, reversibly stimulates both cloned and native TREK-1 channels in striatal neurons. LPA converts the voltage-, intracellular pH-, and stretch-sensitive TREK-1 channel into a leak K ϩ -selective conductance. Rat TREK-1 was reported to behave as a voltage-gated K ϩ channel when phosphorylated by a cAMP-dependent protein kinase, although it become a K ϩ -selective leak conductance when dephosphorylated (45) . However, substitution of serine 333 by an alanine, which abrogates the PKA site (17) , fails to affect the voltage dependence of mouse TREK-1 (22) . Furthermore, in the present study, mTREK-1 remains voltage-dependent even when intracellular cAMP and ATP are lacking. Additionally, the S333A mutant is similarly stimulated by intracellular LPA (n ϭ 5). Differences in species, expression systems, and experimental protocols may explain these apparent discrepancies (22, 45) . FIG. 5 . LPA activation is independent of TREK-1 cytosolic domains and is reversed by the cationic amphipath CPZ. A, effect of intracellular LPA (5 M) (black bars) and AA (5 M) (gray bars) on TREK-1 WT (n ϭ 50 and n ϭ 10, respectively) and NH 2 -and COOH-terminal truncated mutants. The whole amino-terminal domain was deleted in the NH 2 -terminal mutant (for LPA and AA, n ϭ 10 and n ϭ 5, respectively). In the ⌬C mutants, the last 100 (for LPA and AA, n ϭ 14 and n ϭ 7, respectively) and 103 amino acids (for LPA and AA, n ϭ 22 and n ϭ 9, respectively) were deleted (indicated by arrows on the amino acid sequence on top of the histogram). The asterisks indicate significant differences between channel mutants and WT in the presence of LPA or AA. The effect of lipids was determined on inside-out patches at 90 mV. B, TREK-1 channel activity was monitored in the inside-out patch configuration at a holding potential of 0 mV. 50 M CPZ reversibly inhibits the basal as well as the current stimulated by the addition of 5 M LPA to the intracellular medium. C, the same experiment as in B with voltage ramps. The inset shows the effect of CPZ (50 M) on the basal-and the LPA-stimulated (5 mM) TREK-1 currents (n ϭ 4).
The cytosolic carboxyl-terminal domain of TREK-1 plays a key role in the activation by AA and intracellular acidosis (17, 20, 48) . On the contrary, intracellular LPA activation does not involve the amino-and carboxyl-cytosolic domains. Thus, AA, intracellular pH, and LPA open TREK-1 by different mechanisms. Interestingly, the stimulatory effect of intracellular LPA is strongly reduced when the M2M3 intracellular loop of TREK-1 is exchanged with the loop of TRESK-1 (2.7-versus 45-fold increase), another K 2P channel that is not stimulated by intracellular LPA. Although these results may be interpreted in favor of the role of the M2M3 domain in the stimulatory effect of LPA, the strong decrease in the stimulation of the TREK-1/TRESK chimera by other stimuli (e.g. intracellular acidosis, AA, and most importantly, membrane stretch) may also indicate that the general gating properties of TREK-1 are altered by this substitution. However, we cannot entirely rule out the direct involvement of the M2M3 domain in LPA stimulation. Intracellular LPC inhibits TREK-1, further demonstrating that intracellular LPA exerts unique effects (32) . The question remains as to the mechanism of activation by intracellular LPA. Because TREK-1, TREK-2, and TRAAK are mechano-sensitive, a possible mechanism may involve a membrane effect of LPA. Such a mechanism has been recently proposed for the control of synaptic vesicle formation by endophilin I in presynaptic neurons (44) . The LPA acyltransferase activity of endophilin I transfers an arachidonate to LPA and generates PA. Endophilin I is thought to induce a negative membrane curvature by converting the inverted cone-shaped lipid LPA to the cone-shaped lipid PA in the cytoplasmic leaflet of the bilayer, thus promoting vesicle formation (44) . Apparently, the shape of the lipids appears to be important for TREK-1 stimulation, as intracellular PA activates TREK-1 weakly compared with LPA. Moreover, intracellular PA reversibly inhibits TREK-1 channel activity when it has been stimulated previously by AA (35) . Thus, TREK-1 activation would be consistent with a membrane effect of intracellular LPA (44, 53) . Although the present results tend to favor a membrane effect, we cannot entirely rule out the existence of a possible LPA binding site. Although the cytosolic domains of TREK-1 are not involved, we have not eliminated the possibility that LPA could directly interact with the M2M3 domain, the transmembrane segments, and/or the pore regions.
Because TREK-1, TREK-2, TRAAK, and LPA are all present in the brain at high levels, it is worth mentioning some of the LPA effects in the central nervous system. LPA elicits growth cone collapse, neurite retraction, and cell rounding in various neurons, thus suggesting a role in axonal growth and path finding (54) . Hemorrhagic brain injury results in dramatic elevation of this lipid in the cerebrospinal fluid (38) . LPA is also involved in cortical neurogenesis, folding, and growth (55) . Although LPA has been shown to induce cell death of hippocampal neurons, it promotes survival of early postmitotic neurons (38) . LPA is also important for the initiation of neuropathic pain (56) .
In conclusion, the present study demonstrates that intracellular LPA is a potent novel opener of the TREK/TRAAK K 2P channels. Intracellular LPA sensitizes K 2P channels to membrane stretch. Although our results are in favor of a membrane effect of LPA, a possible binding site cannot be entirely ruled out. This novel form of ion channel regulation may be involved in normal physiological functions as well as in various disease states, including neurological disorders.
